- Home
- EAD vs TMCI Comparison
EAD vs TMCI Comparison
Compare EAD & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAD
- TMCI
- Stock Information
- Founded
- EAD 2003
- TMCI 2014
- Country
- EAD United States
- TMCI United States
- Employees
- EAD N/A
- TMCI N/A
- Industry
- EAD Finance/Investors Services
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EAD Finance
- TMCI Health Care
- Exchange
- EAD Nasdaq
- TMCI Nasdaq
- Market Cap
- EAD 416.0M
- TMCI 390.6M
- IPO Year
- EAD N/A
- TMCI 2021
- Fundamental
- Price
- EAD $7.02
- TMCI $5.34
- Analyst Decision
- EAD
- TMCI Hold
- Analyst Count
- EAD 0
- TMCI 5
- Target Price
- EAD N/A
- TMCI $9.42
- AVG Volume (30 Days)
- EAD 178.9K
- TMCI 248.9K
- Earning Date
- EAD 01-01-0001
- TMCI 08-07-2025
- Dividend Yield
- EAD 8.91%
- TMCI N/A
- EPS Growth
- EAD N/A
- TMCI N/A
- EPS
- EAD N/A
- TMCI N/A
- Revenue
- EAD N/A
- TMCI $210,819,000.00
- Revenue This Year
- EAD N/A
- TMCI $10.61
- Revenue Next Year
- EAD N/A
- TMCI $10.41
- P/E Ratio
- EAD N/A
- TMCI N/A
- Revenue Growth
- EAD N/A
- TMCI 7.54
- 52 Week Low
- EAD $5.69
- TMCI $4.54
- 52 Week High
- EAD $6.81
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- EAD 50.86
- TMCI 35.89
- Support Level
- EAD $6.99
- TMCI $5.60
- Resistance Level
- EAD $7.05
- TMCI $5.89
- Average True Range (ATR)
- EAD 0.06
- TMCI 0.28
- MACD
- EAD -0.01
- TMCI -0.05
- Stochastic Oscillator
- EAD 52.38
- TMCI 19.17
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.